A Phase I Study of Immunotherapy With GSC -Loaded Dendritic Cells in Patients With Recurrent Glioblastoma
NCT02820584
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
de Novo Glioblastoma
Interventions
BIOLOGICAL:
GSC-loaded autologous dendritic cells
Sponsor
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta